4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-24-007437
Options or other derivatives
- PRESIDENT AND CEO acquired 879,921 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2024-03-06 | Grant or award · Employee Stock Option (right to buy) | +526,315 | 526,315 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-03-06 | Grant or award · Restricted Stock Units | +353,606 | 353,606 | D | ||
Loading xslF345X05/form4-03082024_110341.xml…